Patent Foramen Ovale in Children With Migraine Headaches

Completed

Conditions studied: Migraine Headaches

In brief

This study will be the first to provide data about the relationship between PFO and migraine in children. By establishing the actual prevalence, we will better understand if PFO plays a role in the occurence of pediatric migraine and, thus, provide the incentive to perform additional studies evaluating whether PFO closure is an effective treatment option for pediatric migraine. For children with migraine headaches, discovering novel and effective treatments would be life altering.

Key facts

Study ID

NCT00750594

Run by

University of Utah

People needed

109

Starts

2008-04-01

Expected to finish

2011-03-01

Last updated by the study team

2017-12-26

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Greater than or equal to six years of age and less than 18 years of age.
• Diagnosis of migraine headache based on the International Headache Society Criteria.
• English speaking patients (and parent/guardians where appropriate).
• Signed informed consent/assent (as appropriate) given by patient, parent or legal guardian.

You may not qualify if…

• Inability to cooperate with imaging studies.
• Known congenital heart disease.
• Parent or guardian is unwilling to have their child undergo contrast echocardiography.

Where it is running

• Primary Children's Medical Center — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.